Given the potential roles of CXCR4 in tumorigenesis, MDA-MB468 cells were then used to study whether Nef-M1 peptide inhibits tumor angiogenesis and EMT through the CXCR4 receptor. This evidence concerns the gene CXCR4 and neoplasm.